Vasopressin Injection, Solution
Product Images NDC 25021-474

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Vasopressin (NDC 25021-474). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Vas03 0000 01)

Structural Formula (Vas03 0000 01)
Chemical structure diagram of vasopressin showing amino acid residues with their positions and side chains in the peptide sequence.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Vas03 0000 02)

Package Label – Principal Display Panel – Vial Label (Vas03 0000 02)
Label for Vasopressin Injection, USP 20 Units per mL single-dose vial by Sagent Pharmaceuticals. It indicates the product is for intravenous infusion, must be diluted before use, and includes storage instructions. The label shows the NDC 25021-474-01 and manufacturing details including origin in India and Sagent Pharmaceuticals' address in Illinois.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.